Efficacy of high-definition transcranial direct current stimulation on craving in substance use disorders: a systematic review and meta-analysis.
High-definition transcranial direct current stimulation is a promising noninvasive method for reducing craving in substance use disorders. This systematic review and meta-analysis evaluates its efficacy. The focus on craving highlights its potential role…
CBD for Brain Tumor Anxiety: What This Trial Found
Advanced cannabis clinical evidence shows that CBD for brain tumor anxiety did not outperform placebo in reducing anxiety or depressive symptoms. This early-terminated randomized trial enrolled adults with primary brain tumors and clinically relevant…
Psychological and Psychosocial Interventions for People With Schizophrenia and Co-Occurring Substance Use Disorders: A Systematic Review and Meta-Analysis.
Psychological interventions schizophrenia substance use are critical for treating patients with dual diagnoses. This systematic review evaluates the efficacy and acceptability of these interventions. Understanding these treatments can improve outcomes…
Cannabidiol in Anorexia Nervosa: A Double-Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change.
This pilot study evaluates cbd anorexia nervosa safety in a randomized, placebo-controlled trial. It focuses on tolerability and pharmacokinetics in affected women. The findings provide preliminary safety data for future research.
Randomized and Blind Evaluation of the Efficacy of a Full-Spectrum Oral
This randomized and blind evaluation investigates the efficacy of full-spectrum oral cannabis extract for chronic osteoarthritis pain. The study provides clinical evidence on pain relief potential. Results highlight the importance of full-spectrum oral…
Assessment of Clinical Factors Predicting Nabilone Response for Agitation in Alzheimer’s
This study investigates nabilone response predictors in treating agitation in Alzheimer's disease. Researchers analyzed clinical factors influencing treatment outcomes. Understanding these predictors may guide personalized cannabinoid therapy for…
Investigating Cannabinoids for Inflammation and Sickle Cell Disease Pain
This protocol outlines a randomized controlled trial investigating dronabinol sickle cell disease pain management. The study evaluates cannabinoids for inflammation and pain reduction. It aims to provide evidence for safer alternatives to opioids in…
Cannabidiol Blood Metabolite Levels and EEG Changes in Autism
This study on autism spectrum disorder cannabidiol research reveals that CBD blood metabolite levels are associated with EEG changes. Boys with autism showed improvements in visuomotor and non-verbal cognitive abilities after cannabidiol treatment. These…
Cannabis Use Among Individuals Treated with Medication for Opioid Use Disorder: Correlates, Patterns, and Motivations for Use.
Cannabis use patterns opioid disorder patients reveal frequent use linked to anxiety and other factors. Understanding these patterns is essential for clinicians managing opioid use disorder. This study highlights motivations and usage trends among…
Probiotics and Palmitoylethanolamide (PEA) for Osteoarthritic Pain: Individual Effects Study
Palmitoylethanolamide osteoarthritis pain management shows promise in recent research. This study used a multiple baseline design to assess PEA and probiotics individually. Findings highlight potential anti-inflammatory benefits for chronic OA pain.